Lori Koch
Director of Finance/CFO bei DUPONT DE NEMOURS, INC.
Vermögen: 8 Mio $ am 31.03.2024
Profil
Gegenwärtig bekleidet Lori D. Koch die Position des Chief Financial Officer & Executive Vice President bei DuPont de Nemours, Inc. und Director, Chief Financial Officer & Executive VP bei Nutrition & Biosciences, Inc. (eine Tochtergesellschaft von DuPont de Nemours, Inc.). Frau Koch ist auch im Vorstand der Aceto Corp. Frau Koch hat einen Hochschulabschluss und einen Bachelor-Abschluss vom Babson College und einen Bachelor-Abschluss von der Pennsylvania State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DUPONT DE NEMOURS, INC.
0,02% | 02.03.2024 | 100 219 ( 0,02% ) | 8 Mio $ | 31.03.2024 |
Aktive Positionen von Lori Koch
| Unternehmen | Position | Beginn |
|---|---|---|
| DUPONT DE NEMOURS, INC. | Director of Finance/CFO | 17.02.2020 |
| ACETO CORPORATION | Director/Board Member | 01.12.2019 |
Nutrition & Biosciences, Inc.
 Nutrition & Biosciences, Inc. Chemicals: Major DiversifiedProcess Industries Nutrition & Biosciences, Inc. manufactures and distributes food & beverages, dietary supplements, and pharmaceutical products. The company is headquartered in Wilmington, DE. | Director of Finance/CFO | - |
Ehemalige bekannte Positionen von Lori Koch
| Unternehmen | Position | Ende |
|---|---|---|
| E I DU PONT DE NEMOURS AND CO | Director of Finance/CFO | - |
Ausbildung von Lori Koch
| Babson College | Graduate Degree |
| The Pennsylvania State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DUPONT DE NEMOURS, INC. | Process Industries |
| Private Unternehmen | 3 |
|---|---|
Actylis Corp.
 Actylis Corp. Pharmaceuticals: GenericHealth Technology Actylis Corp. engages in the development, marketing, sale, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment supplies active pharmaceutical ingredients and pharmaceutical intermediates. The Performance Chemicals segment comprises of specialty chemicals and agricultural protection products. The company was founded in 1947 and is headquartered in Port Washington, NY. | Health Technology |
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Nutrition & Biosciences, Inc.
Nutrition & Biosciences, Inc. Chemicals: Major DiversifiedProcess Industries Nutrition & Biosciences, Inc. manufactures and distributes food & beverages, dietary supplements, and pharmaceutical products. The company is headquartered in Wilmington, DE. | Process Industries |
